2019 - Drug Manufacturing Inspection Part III
Date2019-12-19
Deadline2019-12-19
VenueOnline Event, USA - United States
KeywordsFDA Surveillance Inspections; FDA For Cause Inspection; Compliance Program 7356.002
Topics/Call fo Papers
The following topics will be addressed during this webinar:
Background
Objectives and Strategy Related to the Compliance Program 7356.002
Strategy Related to the Compliance Program 7356.002
Scheme of Systems for the Manufacture of Drugs/Drug Products
Program Management
Investigational Operations
Analytical
Typical Deficiencies Found as a Result of Systems Inspected
Background
Objectives and Strategy Related to the Compliance Program 7356.002
Strategy Related to the Compliance Program 7356.002
Scheme of Systems for the Manufacture of Drugs/Drug Products
Program Management
Investigational Operations
Analytical
Typical Deficiencies Found as a Result of Systems Inspected
Other CFPs
- Tips on Dealing with Securities Regulatory Authorities - Audits, Etc
- I-9 Audits: Strengthening Your Immigration Compliance Strategies
- Stability Studies and Estimating Shelf Life
- Enhancing Audit Advisory Practices
- Data Blocking and Patient Access of Medical Records under HIPAA - New Focus of Enforcement and Guidance
Last modified: 2019-11-07 21:54:26